Heilongjiang ZBD Pharmaceutical Co Ltd (603567) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥283.54 Million ≈ $41.49 Million USD) by net assets (CN¥7.29 Billion ≈ $1.07 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Heilongjiang ZBD Pharmaceutical Co Ltd (603567) market capitalisation for the company's overall valuation and market capitalisation.

Heilongjiang ZBD Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Heilongjiang ZBD Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Heilongjiang ZBD Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heilongjiang ZBD Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Heilongjiang ZBD Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SGSG Science&technology Co Ltd Zhuhai SHE:300561	0.008x
Barclays PLC LSE:BARC	0.235x
Innova Captab Limited NSE:INNOVACAP	0.027x
Shenzhen Jinjia Color Printing Group Co Ltd SHE:002191	0.050x
Southern Cable Group Bhd KLSE:0225	0.036x
Chief Telecom Inc TWO:6561	0.122x
Shenzhen Grandland Decoration Group Co Ltd SHE:002482	0.133x
Obsidian Energy Ltd TO:OBE	0.027x

Annual Cash Flow Conversion Efficiency for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025. View Heilongjiang ZBD Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.28 Billion ≈ $918.84 Million	CN¥322.10 Million ≈ $47.13 Million	0.051x	+158.84%
2024-12-31	CN¥8.29 Billion ≈ $1.21 Billion	CN¥164.31 Million ≈ $24.04 Million	0.020x	+134.80%
2023-12-31	CN¥8.04 Billion ≈ $1.18 Billion	CN¥-457.90 Million ≈ $-67.00 Million	-0.057x	-23.85%
2022-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥-326.79 Million ≈ $-47.82 Million	-0.046x	+25.28%
2021-12-31	CN¥7.05 Billion ≈ $1.03 Billion	CN¥-433.94 Million ≈ $-63.50 Million	-0.062x	-318.25%
2020-12-31	CN¥5.50 Billion ≈ $805.28 Million	CN¥155.18 Million ≈ $22.71 Million	0.028x	-32.99%
2019-12-31	CN¥5.25 Billion ≈ $768.26 Million	CN¥220.92 Million ≈ $32.33 Million	0.042x	-42.93%
2018-12-31	CN¥4.98 Billion ≈ $729.21 Million	CN¥367.40 Million ≈ $53.76 Million	0.074x	-59.57%
2017-12-31	CN¥4.68 Billion ≈ $684.71 Million	CN¥853.19 Million ≈ $124.85 Million	0.182x	+4862.02%
2016-12-31	CN¥4.31 Billion ≈ $630.20 Million	CN¥15.83 Million ≈ $2.32 Million	0.004x	+104.52%
2015-12-31	CN¥3.98 Billion ≈ $582.63 Million	CN¥-323.90 Million ≈ $-47.40 Million	-0.081x	-145.75%
2014-12-31	CN¥2.17 Billion ≈ $317.92 Million	CN¥386.32 Million ≈ $56.53 Million	0.178x	+77.83%
2013-12-31	CN¥1.75 Billion ≈ $255.64 Million	CN¥174.68 Million ≈ $25.56 Million	0.100x	-14.48%
2012-12-31	CN¥1.32 Billion ≈ $193.04 Million	CN¥154.25 Million ≈ $22.57 Million	0.117x	+3.07%
2011-12-31	CN¥923.09 Million ≈ $135.08 Million	CN¥104.71 Million ≈ $15.32 Million	0.113x	--

About Heilongjiang ZBD Pharmaceutical Co Ltd

SHG:603567 China Drug Manufacturers - Specialty & Generic

Market Cap

$758.10 Million

CN¥5.18 Billion CNY

Market Cap Rank

#10305 Global

#2781 in China

Share Price

CN¥5.51

Change (1 day)

-0.90%

52-Week Range

CN¥4.28 - CN¥12.08

All Time High

CN¥28.17